Search Results - Azzanelli, Ylenia

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Excellent Outcome in NPM1- mutated Acute Myeloid Leukemia Patients Receiving Intensified Fludarabine-Based Induction Is Not Affected By Secondary Type Mutations and Other High Risk Aberrations

    Excellent Outcome in NPM1- mutated Acute Myeloid Leukemia Patients Receiving Intensified Fludarabine-Based Induction Is Not Affected By Secondary Type Mutations and Other High Risk... by Minetto, Paola, Riva, Carola, Carminati, Enrico, Azzanelli, Ylenia, Puglisi, Francesco, Nurra, Clara, Fugazza, Giuseppina, Cagnetta, Antonia, Cea, Michele, Lemoli, Roberto Massimo, Guolo, Fabio

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Comparing Outcomes between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease

    Comparing Outcomes between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease by Riva, Carola, Minetto, Paola, Chies, Maria, Maio, Elena, Azzanelli, Ylenia, Zecchetti, Giada, Colombo, Nicoletta, Rosellini, Sara, Parodi, Alessia, Tedone, Elisabetta, Carminati, Enrico, Fugazza, Giuseppina, Nozza, Paolo, Cea, Michele, Lemoli, Roberto Massimo, Guolo, Fabio

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Real World Evidence of Efficacy of CPX-351 in Secondary Acute Myeloid Leukemia Defined According to Who 2022 Classification

    Real World Evidence of Efficacy of CPX-351 in Secondary Acute Myeloid Leukemia Defined According to Who 2022 Classification by Riva, Carola, Minetto, Paola, Chies, Maria, Vernarecci, Chiara, Zecchetti, Giada, Maio, Elena, Azzanelli, Ylenia, Colombo, Nicoletta, Rosellini, Sara, Parodi, Alessia, Tedone, Elisabetta, Carminati, Enrico, Puglisi, Francesco, Nurra, Clara, Fugazza, Giuseppina, Nozza, Paolo, Cea, Michele, Lemoli, Roberto Massimo, Guolo, Fabio

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    High Risk Mutations in Critical Genes Do Not Significantly Affect Remission Rates and Minimal Residual Disease Clearance in Acute Myeloid Leukemia Patients Receiving CPX-351 Induction

    High Risk Mutations in Critical Genes Do Not Significantly Affect Remission Rates and Minimal Residual Disease Clearance in Acute Myeloid Leukemia Patients Receiving CPX-351 Induct... by Guolo, Fabio, Riva, Carola, Chies, Maria, Vernarecci, Chiara, Azzanelli, Ylenia, Colombo, Nicoletta, Rosellini, Sara, Parodi, Alessia, Tedone, Elisabetta, Carminati, Enrico, Puglisi, Francesco, Nurra, Clara, Fugazza, Giuseppina, Cea, Michele, Lemoli, Roberto Massimo, Minetto, Paola

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: